Global Needle Free Injection Systems Market Research Report 2019 by Manufacturers, Regions, Types and Applications
Table of Contents
1 Executive Summary
- 1.1 Definition and Specification
- 1.2 Report Overview
- 1.2.1 Manufacturers Overview
- 1.2.2 Regions Overview
- 1.2.3 Type Overview
- 1.2.4 Application Overview
- 1.3 Industrial Chain
- 1.3.1 Needle Free Injection Systems Overall Industrial Chain
- 1.3.2 Upstream
- 1.3.3 Downstream
- 1.4 Industry Situation
- 1.4.1 Industrial Policy
- 1.4.2 Product Preference
- 1.4.3 Economic/Political Environment
- 1.5 SWOT Analysis
2 Market Analysis by Types
- 2.1 Overall Market Performance(Volume)
- 2.1.1 Liquid-Based Needle-Free Injectors
- 2.1.2 Projectile/Depot-Based Needle-Free Injectors
- 2.1.3 Powder-Based Needle Free Injectors
- 2.2 Overall Market Performance(Value)
- 2.2.1 Liquid-Based Needle-Free Injectors
- 2.2.2 Projectile/Depot-Based Needle-Free Injectors
- 2.2.3 Powder-Based Needle Free Injectors
3 Product Application Market
- 3.1 Overall Market Performance (Volume)
- 3.1.1 Vaccine Delivery
- 3.1.2 Insulin Delivery
- 3.1.3 Oncology
- 3.1.4 Pain Management
- 3.1.5 Others
4 Manufacturers Profiles/Analysis
- 4.1 Antares Pharma, Inc. (U.S.)
- 4.1.1 Antares Pharma, Inc. (U.S.) Profiles
- 4.1.2 Antares Pharma, Inc. (U.S.) Product Information
- 4.1.3 Antares Pharma, Inc. (U.S.) Needle Free Injection Systems Sales, Sales Value(Million USD), Price and Gross Profit
- 4.1.4 Antares Pharma, Inc. (U.S.) SWOT Analysis
- 4.2 Endo International plc (U.S.)
- 4.2.1 Endo International plc (U.S.) Profiles
- 4.2.2 Endo International plc (U.S.) Product Information
- 4.2.3 Endo International plc (U.S.) Needle Free Injection SystemsSales, Sales Value (Million USD), Price and Gross Profit
- 4.2.4 Endo International plc (U.S.) SWOT Analysis
- 4.3 PharmaJet (U.S)
- 4.3.1 PharmaJet (U.S) Profiles
- 4.3.2 PharmaJet (U.S) Product Information
- 4.3.3 PharmaJet (U.S) Needle Free Injection SystemsSales, Sales Value (Million USD), Price and Gross Profit
- 4.3.4 PharmaJet (U.S) SWOT Analysis
- 4.4 Bioject Medical Technologies Inc. (U.S)
- 4.4.1 Bioject Medical Technologies Inc. (U.S) Profiles
- 4.4.2 Bioject Medical Technologies Inc. (U.S) Product Information
- 4.4.3 Bioject Medical Technologies Inc. (U.S) Needle Free Injection SystemsSales, Sales Value (Million USD), Price and Gross Profit
- 4.4.4 Bioject Medical Technologies Inc. (U.S) SWOT Analysis
- 4.5 Medical International Technology, Inc. (U.S)
- 4.5.1 Medical International Technology, Inc. (U.S) Profiles
- 4.5.2 Medical International Technology, Inc. (U.S) Product Information
- 4.5.3 Medical International Technology, Inc. (U.S) Needle Free Injection SystemsSales, Sales Value (Million USD), Price and Gross Profit
- 4.5.4 Medical International Technology, Inc. (U.S) SWOT Analysis
- 4.6 INJEX Pharma AG (Germany)
- 4.6.1 INJEX Pharma AG (Germany) Profiles
- 4.6.2 INJEX Pharma AG (Germany) Product Information
- 4.6.3 INJEX Pharma AG (Germany) Needle Free Injection SystemsSales, Sales Value (Million USD), Price and Gross Profit
- 4.6.4 INJEX Pharma AG (Germany) SWOT Analysis
- 4.7 National Medical Products Inc. (U.S.)
- 4.7.1 National Medical Products Inc. (U.S.) Profiles
- 4.7.2 National Medical Products Inc. (U.S.) Product Information
- 4.7.3 National Medical Products Inc. (U.S.) Needle Free Injection SystemsSales, Sales Value (Million USD), Price and Gross Profit
- 4.7.4 National Medical Products Inc. (U.S.) SWOT Analysis
- 4.8 Valeritas, Inc. (U.S.)
- 4.8.1 Valeritas, Inc. (U.S.) Profiles
- 4.8.2 Valeritas, Inc. (U.S.) Product Information
- 4.8.3 Valeritas, Inc. (U.S.) Needle Free Injection SystemsSales, Sales Value (Million USD), Price and Gross Profit
- 4.8.4 Valeritas, Inc. (U.S.) SWOT Analysis
- 4.9 European Pharma Group (Netherland)
- 4.9.1 European Pharma Group (Netherland) Profiles
- 4.9.2 European Pharma Group (Netherland) Product Information
- 4.9.3 European Pharma Group (Netherland) Needle Free Injection SystemsSales, Sales Value (Million USD), Price and Gross Profit
- 4.9.4 European Pharma Group (Netherland) SWOT Analysis
- 4.10 PenJet Corporation (U.S)
- 4.10.1 PenJet Corporation (U.S) Profiles
- 4.10.2 PenJet Corporation (U.S) Product Information
- 4.10.3 PenJet Corporation (U.S) Needle Free Injection SystemsSales, Sales Value (Million USD), Price and Gross Profit
- 4.10.4 PenJet Corporation (U.S) SWOT Analysis
- 4.11 Crossject SA (France)
5 Market Performance for Manufacturers
- 5.1 Global Needle Free Injection Systems Sales (K Units) and Market Share by Manufacturers 2014-2020
- 5.2 Global Needle Free Injection Systems Revenue (M USD) and Market Share by Manufacturers 2014-2020
- 5.3 Global Needle Free Injection Systems Price (USD/Unit) of Manufacturers 2014-2020
- 5.4 Global Needle Free Injection Systems Gross Margin of Manufacturers 2014-2020
- 5.5 Market Concentration
6 Regions Market Performance for Manufacturers
- 6.1 China Market Performance for Manufacturers
- 6.1.1 China Needle Free Injection Systems Sales (K Units) and Share of Manufacturers 2014-2020
- 6.1.2 China Needle Free Injection Systems Revenue (M USD) and Share of Manufacturers 2014-2020
- 6.1.3 China Needle Free Injection Systems Price (USD/Unit) of Manufacturers 2014-2020
- 6.1.4 China Needle Free Injection Systems Gross Margin of Manufacturers 2014-2020
- 6.1.5 Market Concentration
- 6.2 USA Market Performance for Manufacturers
- 6.2.1 USA Needle Free Injection Systems Sales (K Units) and Share of Manufacturers 2014-2020
- 6.2.2 USA Needle Free Injection Systems Revenue (M USD) and Share of Manufacturers 2014-2020
- 6.2.3 USA Needle Free Injection Systems Price (USD/Unit) of Manufacturers 2014-2020
- 6.2.4 USA Needle Free Injection Systems Gross Margin of Manufacturers 2014-2020
- 6.2.5 Market Concentration
- 6.3 Europe Market Performance for Manufacturers
- 6.3.1 Europe Needle Free Injection Systems Sales (K Units) and Share of Manufacturers 2014-2020
- 6.3.2 Europe Needle Free Injection Systems Revenue (M USD) and Share of Manufacturers 2014-2020
- 6.3.3 Europe Needle Free Injection Systems Price (USD/Unit) of Manufacturers 2014-2020
- 6.3.4 Europe Needle Free Injection Systems Gross Margin of Manufacturers 2014-2020
- 6.3.5 Market Concentration
- 6.4 Japan Market Performance for Manufacturers
- 6.4.1 Japan Needle Free Injection Systems Sales (K Units) and Share of Manufacturers 2014-2020
- 6.4.2 Japan Needle Free Injection Systems Revenue (M USD) and Share of Manufacturers 2014-2020
- 6.4.3 Japan Needle Free Injection Systems Price (USD/Unit) of Manufacturers 2014-2020
- 6.4.4 Japan Needle Free Injection Systems Gross Margin of Manufacturers 2014-2020
- 6.4.5 Market Concentration
- 6.5 Korea Market Performance for Manufacturers
- 6.5.1 Korea Needle Free Injection Systems Sales (K Units) and Share of Manufacturers 2014-2020
- 6.5.2 Korea Needle Free Injection Systems Revenue (M USD) and Share of Manufacturers 2014-2020
- 6.5.3 Korea Needle Free Injection Systems Price (USD/Unit) of Manufacturers 2014-2020
- 6.5.4 Korea Needle Free Injection Systems Gross Margin of Manufacturers 2014-2020
- 6.5.5 Market Concentration
- 6.6 India Market Performance for Manufacturers
- 6.6.1 India Needle Free Injection Systems Sales (K Units) and Share of Manufacturers 2014-2020
- 6.6.2 India Needle Free Injection Systems Revenue (M USD) and Share of Manufacturers 2014-2020
- 6.6.3 India Needle Free Injection Systems Price (USD/Unit) of Manufacturers 2014-2020
- 6.6.4 India Needle Free Injection Systems Gross Margin of Manufacturers 2014-2020
- 6.6.5 Market Concentration
- 6.7 Southeast Asia Market Performance for Manufacturers
- 6.7.1 Southeast Asia Needle Free Injection Systems Sales (K Units) and Share of Manufacturers 2014-2020
- 6.7.2 Southeast Asia Needle Free Injection Systems Revenue (M USD) and Share of Manufacturers 2014-2020
- 6.7.3 Southeast Asia Needle Free Injection Systems Price (USD/Unit) of Manufacturers 2014-2020
- 6.7.4 Southeast Asia Needle Free Injection Systems Gross Margin of Manufacturers 2014-2020
- 6.7.5 Market Concentration
- 6.8 South America Market Performance for Manufacturers
- 6.8.1 South America Needle Free Injection Systems Sales (K Units) and Share of Manufacturers 2014-2020
- 6.8.2 South America Needle Free Injection Systems Revenue (M USD) and Share of Manufacturers 2014-2020
- 6.8.3 South America Needle Free Injection Systems Price (USD/Unit) of Manufacturers 2014-2020
- 6.8.4 South America Needle Free Injection Systems Gross Margin of Manufacturers 2014-2020
- 6.8.5 Market Concentration
7 Global Needle Free Injection Systems Market Assessment by Regions (2014-2020)
- 7.1 Global Needle Free Injection Systems Sales (K Units) and Market Share by Regions 2014-2020
- 7.2 Global Needle Free Injection Systems Revenue (M USD) and Market Share by Regions 2014-2020
- 7.3 Global Needle Free Injection Systems Price (USD/Unit) by Regions 2014-2020
- 7.4 Global Needle Free Injection Systems Gross Margin by Regions 2014-2020
8 Development Trend for Regions
- 8.1 Global Needle Free Injection Systems Sales and Growth, Sales Value and Growth Rate 2014-2020
- 8.2 China Needle Free Injection Systems Sales and Growth, Sales Value and Growth Rate 2014-2020
- 8.3 USA Needle Free Injection Systems Sales and Growth, Sales Value and Growth Rate2014-2020
- 8.4 Europe Needle Free Injection Systems Sales and Growth, Sales Value and Growth Rate 2014-2020
- 8.5 Japan Needle Free Injection Systems Sales and Growth, Sales Value and Growth Rate 2014-2020
- 8.6 Korea Needle Free Injection Systems Sales and Growth, Sales Value and Growth Rate 2014-2020
- 8.7 India Needle Free Injection Systems Sales and Growth, Sales Value and Growth Rate 2014-2020
- 8.8 Southeast Asia Needle Free Injection Systems Sales and Growth, Sales Value and Growth Rate 2014-2020
- 8.8 Southeast Asia Needle Free Injection Systems Sales and Growth, Sales Value and Growth Rate 2014-2020
9 Upstream Source, Technology and Cost
- 9.1 Upstream Source
- 9.2 Technology
- 9.3 Cost
10 Channel Analysis
- 10.1 Market Channel
- 10.2 Manufacturing Plants Distribution
11 Consumer Analysis
- 11.1 Vaccine Delivery Industry
- 11.2 Insulin Delivery Industry
- 11.3 Oncology Industry
- 11.4 Pain Management Industry
- 11.5 Others Industry
12 Market Forecast 2021-2026
- 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2021-2026
- 12.1.1 Global Needle Free Injection Systems Sales (K Units), Revenue (M USD) and Market Share by Regions 2021-2026
- 12.1.2 Global Needle Free Injection Systems Sales (K Units) and Growth Rate 2021-2026
- 12.1.3 China Needle Free Injection Systems Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
- 12.1.4 USA Needle Free Injection Systems Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
- 12.1.5 Europe Needle Free Injection Systems Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
- 12.1.6 Japan Needle Free Injection Systems Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
- 12.1.7 Korea Needle Free Injection Systems Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
- 12.1.8 India Needle Free Injection Systems Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
- 12.1.9 Southeast Asia Needle Free Injection Systems Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
- 12.1.10 South America Needle Free Injection Systems Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
- 12.2 Sales (K Units), Revenue (M USD) Forecast by Types 2021-2026
- 12.2.1 Overall Market Performance
- 12.2.2 Liquid-Based Needle-Free Injectors
- 12.2.3 Projectile/Depot-Based Needle-Free Injectors
- 12.2.4 Powder-Based Needle Free Injectors
- 12.3 Sales (K Units) Forecast by Application 2021-2026
- 12.3.1 Overall Market Performance
- 12.3.2 Vaccine Delivery
- 12.3.3 Insulin Delivery
- 12.3.4 Oncology
- 12.3.5 Pain Management
- 12.3.6 Others
- 12.4 Price (USD/Unit) and Gross Profit
- 12.4.1 Global Needle Free Injection Systems Price (USD/Unit) Trend 2021-2026
- 12.4.2 Global Needle Free Injection Systems Gross Profit Trend 2021-2026
13 Conclusion
According to XYZResearch study, over the next five years the Needle Free Injection Systemsmarket will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026, from US$ xx million in 2020. In particular, this report presents the global market share (sales and revenue) of key companies in Needle Free Injection Systemsbusiness.
Needle Free Injection Systems market development trend, sales volume and sales value (million USD) forecast in regional market, the main regions are China, USA, Europe, India, Japan, Korea, South America, Southeast Asia.
Sales forecast by type/application from 2021-2026
Industry chain, downstream and upstream information is also included.
World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war.
Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO. The decline in exports has been mainly due to the ongoing global slowdown, which got aggravated due to the current Covid-19 crisis. The latter resulted in large scale disruptions in supply chains and demand resulting in cancellation of orders.
XYZResearch’s analysis shows that as China started reopening its economy, world exports initially recovered across the board. But estimates of the expected recovery in 2021 are uncertain, with outcomes depending largely on the duration of the outbreak and the effectiveness of the policy responses.
This report split global into several key Regions, with sales (K Units), revenue (M USD), market share and growth rate of Needle Free Injection Systems for these regions, from 2014 to 2026 (forecast), covering
China
USA
Europe
Japan
Korea
India
Southeast Asia
South America
Global Needle Free Injection Systems market competition by top manufacturers/players, with Needle Free Injection Systems sales volume, Price (USD/Unit), revenue (M USD) and market share for each manufacturer/player; the top players including
Antares Pharma, Inc. (U.S.)
Endo International plc (U.S.)
PharmaJet (U.S)
Bioject Medical Technologies Inc. (U.S)
Medical International Technology, Inc. (U.S)
INJEX Pharma AG (Germany)
National Medical Products Inc. (U.S.)
Valeritas, Inc. (U.S.)
European Pharma Group (Netherland)
PenJet Corporation (U.S)
Crossject SA (France)
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Liquid-Based Needle-Free Injectors
Projectile/Depot-Based Needle-Free Injectors
Powder-Based Needle Free Injectors
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Needle Free Injection Systems for each application, including
Vaccine Delivery
Insulin Delivery
Oncology
Pain Management
Others
Feel free to let me know if you have any special requirements.